Hitting a Nerve

Mechanism of Action


 

MOA — Mechanism of action — gets bandied about a lot.

Drug reps love it. Saying your product is a “first-in-class MOA” sounds great as they hand you a glossy brochure. It also features prominently in print ads, usually with pics of smiling people.

It’s a good thing to know, too, both medically and in a cool-science-geeky way. We want to understand what we’re prescribing will do to patients. We want to explain it to them, too.

Dr. Allan M. Block, a neurologist in Scottsdale, Arizona.

Dr. Allan M. Block

It certainly helps to know that what we’re doing when treating a disorder using rational polypharmacy.

But at the same time we face the realization that it may not mean as much as we think it should. I don’t have to go back very far in my career to find Food and Drug Administration–approved medications that worked, but we didn’t have a clear reason why. I mean, we had a vague idea on a scientific basis, but we’re still guessing.

This didn’t stop us from using them, which is nothing new. The ancients had learned certain plants reduced pain and fever long before they understood what aspirin (and its MOA) was.

At the same time we’re now using drugs, such as the anti-amyloid treatments for Alzheimer’s disease, that should be more effective than one would think. Pulling the damaged molecules out of the brain should, on paper, make a dramatic difference ... but it doesn’t. I’m not saying they don’t have some benefit, but certainly not as much as you’d think. Of course, that’s based on our understanding of the disease mechanism being correct. We find there’s a lot more going on than we know.

Like so much in science (and this aspect of medicine is a science) the answers often lead to more questions.

Observation takes the lead over understanding in most things. Our ancestors knew what fire was, and how to use it, without any idea of what rapid exothermic oxidation was. (Admittedly, I have a degree in chemistry and can’t explain it myself anymore.)

The glossy ads and scientific data about MOA doesn’t mean much in my world if they don’t work. I’d rather have a drug that works, even if the MOA isn’t clear, than a known MOA without clinical benefit. My patients would say the same.

Clinical medicine, after all, is both an art and a science.

Dr. Block has a solo neurology practice in Scottsdale, Arizona.

Recommended Reading

Flash Drive Versus Paper
MDedge Neurology
Prominent NIH Neuroscientist Fired Over Alleged Research Misconduct
MDedge Neurology
A Few Rural Towns Are Bucking the Trend and Building New Hospitals
MDedge Neurology
Millennial Clinicians Face Pay Disparities by Specialty, Other Factors
MDedge Neurology
Women Are Entering Higher-Paid MD Specialties at Higher Rates
MDedge Neurology
Why Residents Are Joining Unions in Droves
MDedge Neurology
How AI Is Revolutionizing Drug Repurposing for Faster, Broader Impact
MDedge Neurology
Lawsuit Targets Publishers: Is Peer Review Flawed?
MDedge Neurology
NY Nurse Practitioners Sue State Over Pay Equity, Alleged Gender Inequality
MDedge Neurology
A Hard Look at Toxic Workplace Culture in Medicine
MDedge Neurology